8-K: Israel Acquisitions Corp Amends Business Combination Agreement with Gadfin Ltd., Revising Valuation and Key Merger Terms

Israel Acquisitions Corp (ISRL) and Gadfin Ltd. amended their business combination agreement, revising the Company Equity Value to $180 million and adjusting other key terms for their proposed merger, with NewPubco joining the agreement.

Summary

• Israel Acquisitions Corp (ISRL) and Gadfin Ltd. entered into Amendment No. 1 to their Business Combination Agreement (BCA) on July 2, 2025.
• Gadfin Regev Holdings Ltd. (NewPubco) became a party to the BCA as of January 26, 2025, through this amendment.
• The amendment removed the requirement for ISRL to liquidate immediately following the Mergers.
• The Company Equity Value was revised to $180,000,000.
• Provisions related to PCAOB Related Default and Threshold Raised Amount were removed from the BCA.
• The maximum dilution calculation was clarified, stating that 'Covered Shares' (Sponsor Shares, SPAC Shares, and PIPE Shares) shall not exceed 30% of NewPubco's issued and outstanding share capital upon Closing.
• The Sponsor may be required to forfeit up to 1,429,000 Sponsor Shares to reduce aggregate Covered Shares below the Dilution Cap, while maintaining a minimum of 4,000,000 Sponsor Shares.
• The deadline for the Benchmark Analysis of compensation packages for post-closing officers and directors was extended to September 30, 2025.
• Gadfin gained a termination right, without penalty, if ISRL does not receive a full cash waiver from underwriters for deferred underwriting fees within 30 days of July 2, 2025.
• A confidential draft of a Registration Statement on Form F-4 was submitted to the SEC on July 2, 2025, regarding the proposed business combination.

Sentiment

Score: 6

Explanation: The amendment signifies continued progress towards the business combination with Gadfin, including the critical step of submitting the F-4 registration statement. However, the introduction of a new termination right for Gadfin related to underwriting fees and potential sponsor share forfeiture adds elements of risk and complexity. The revised valuation is a factual change without context for sentiment.

Positives

• The execution of Amendment No. 1 and the joinder of NewPubco indicate continued progress towards the consummation of the business combination.
• The submission of a confidential draft of the Registration Statement on Form F-4 to the SEC is a significant step forward in the merger process.
• The removal of the requirement for Israel Acquisitions Corp to liquidate immediately following the mergers provides more flexibility for the SPAC.

Negatives

• Gadfin now has a termination right if Israel Acquisitions Corp does not secure a full cash waiver for deferred underwriting fees within 30 days, indicating a potential financial hurdle for ISRL.
• The Sponsor faces potential forfeiture of up to 1,429,000 Sponsor Shares if the aggregate 'Covered Shares' exceed the 30% dilution cap, which could impact sponsor economics.

Risks

• Changes in domestic and foreign business conditions.
• Changes in the competitive environment in which Gadfin operates.
• Gadfin's ability to manage its growth prospects, meet operational and financial targets, and execute its strategy.
• The impact of economic disruptions, decreased market demand, and other macroeconomic factors, including the effect of a global pandemic, on Gadfin's business, projected results of operations, financial performance, or other financial metrics.
• Gadfin's reliance on its senior management team and key employees.
• Risks related to liquidity, capital resources, and capital expenditures.
• Failure to comply with applicable laws and regulations or changes in the regulatory environment in which Gadfin operates.
• The outcome of any potential litigation, government and regulatory proceedings, investigations, and inquiries that Gadfin may face.
• Assumptions or analyses used for Gadfin's forecasts proving to be incorrect and causing its actual operating and financial results to be significantly below its forecasts, including the inability to sign new contracts or secure necessary financial resources as anticipated.
• An acquisition not occurring as planned and negatively affecting operating results.
• The inability of the parties to successfully or timely consummate the Transactions, including the risk that any required regulatory approvals are not obtained, are delayed, or are subject to unanticipated conditions.
• The risk that the approval of the shareholders of Israel Acquisitions Corp is not obtained.
• The risk that shareholders of Israel Acquisitions Corp could elect to have their shares redeemed, leaving NewPubco with insufficient cash to complete the Transactions or grow its business.
• Failure to realize the anticipated benefits of the Transactions.
• Risks relating to the uncertainty of the projected financial information with respect to Gadfin.
• The effects of competition.
• Changes in applicable laws or regulations.
• The ability of Gadfin to manage expenses and recruit and retain key employees.
• The ability of Israel Acquisitions Corp or NewPubco to issue equity or equity-linked securities in connection with the Transactions or in the future.
• A potential U.S. government shutdown.
• The impact of certain geopolitical events, including wars in Ukraine and the surrounding region, the war between Israel and Hamas, the war between Israel and Iran, and conflict in the Middle East.
• The impact of a future pandemic on Gadfin, Israel Acquisitions Corp, or NewPubco's projected results of operations, financial performance, or other financial metrics.

Future Outlook

The parties are actively working towards the consummation of the Business Combination, as evidenced by the submission of the confidential F-4 Registration Statement. The combined company plans to conduct a benchmark analysis for officer and director compensation by September 30, 2025, to align with public market practices. The forward-looking statements indicate expectations for financial and operational metrics and the successful completion of the Transactions, while acknowledging various inherent risks and uncertainties.

Management Comments

• No specific notable quotes or paraphrased statements from company management regarding strategic direction or performance were included in this filing, beyond the formal execution of the agreement by Ziv Elul (CEO and Director of Israel Acquisitions Corp) and Eyal Regev (CEO & Director of Gadfin Ltd. and Sole-Director of Gadfin Regev Holdings Ltd.).

Industry Context

This filing details an amendment to a business combination agreement, a common occurrence in SPAC (Special Purpose Acquisition Company) mergers. Such amendments often reflect ongoing negotiations, due diligence findings, or adjustments to market conditions. The mention of geopolitical risks, including conflicts in the Middle East, highlights the broader external factors that can influence international business combinations and investor sentiment.

Corporate Governance

Related Party Transactions

• The Sponsor (Israel Acquisitions Sponsor LLC) may be required to forfeit up to 1,429,000 Sponsor Shares if the aggregate 'Covered Shares' (which include Sponsor Shares) exceed 30% of NewPubco's issued and outstanding share capital upon Closing, though the Sponsor shall not hold less than 4,000,000 Sponsor Shares.

Stakeholder Impact

• **Shareholders (Israel Acquisitions Corp):** Will receive a definitive proxy statement/prospectus and are urged to review it before making voting or investment decisions. They face the risk of their shares being redeemed, which could impact the cash available for the combined company.
• **Shareholders (Gadfin/NewPubco):** Will become shareholders of NewPubco upon the consummation of the business combination.
• **Underwriters:** The deferred underwriting fees owed by Israel Acquisitions Corp are a point of negotiation, with Gadfin gaining a termination right if a full cash waiver is not secured, potentially impacting the underwriters' expected fees.
• **Officers and Directors (NewPubco):** Their compensation packages will be subject to a benchmark analysis by September 30, 2025, to align with public market practices, potentially affecting their future remuneration.

Next Steps

• The Company (Gadfin) shall use reasonable best efforts to deliver required financial statements for the Registration Statement/Proxy Statement.
• An independent compensation consultant will conduct a benchmark analysis of compensation packages for officers and directors of the combined company, with recommendations to be presented to Gadfin's Board by September 30, 2025.
• The definitive proxy statement/prospectus will be sent to the shareholders of Israel Acquisitions Corp.
• Israel Acquisitions Corp and Gadfin will file other documents regarding the Transactions with the SEC.
• Investors and security holders of Israel Acquisitions Corp are urged to read the definitive proxy statement/prospectus and all other relevant documents before making any voting or investment decisions.
• The parties aim to consummate the Business Combination.

Key Dates

Recommendation

Keywords

Business Combination, SPAC, Merger, Gadfin, Israel Acquisitions Corp, SEC Filing, 8-K, Corporate Governance, Valuation, Dilution, Underwriting Fees, F-4 Registration Statement